SUSQUEHANNA INTERNATIONAL GROUP, LLP - ARCTURUS THERAPEUTICS LTD ownership

ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105. A total of 21 filers reported holding ARCTURUS THERAPEUTICS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ARCTURUS THERAPEUTICS LTD
ValueSharesWeighting
Q1 2019$78,000
-56.2%
11,400
-71.0%
0.00%
Q4 2018$178,000
-6.8%
39,351
+82.4%
0.00%
Q3 2018$191,000
-14.7%
21,572
-18.3%
0.00%
Q2 2018$224,000
+128.6%
26,418
+114.8%
0.00%
Q4 2017$98,00012,3000.00%
Other shareholders
ARCTURUS THERAPEUTICS LTD shareholders Q1 2019
NameSharesValueWeighting ↓
ARK Investment Management 533,773$4,526,0000.17%
ROYCE & ASSOCIATES LP 106,436$903,0000.01%
OXFORD ASSET MANAGEMENT LLP 37,007$326,0000.01%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 27,300$232,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 1,100$9,0000.00%
GROUP ONE TRADING, L.P. 2,801$24,0000.00%
1832 Asset Management L.P. 560$5,0000.00%
CITIGROUP INC 171$1,0000.00%
BlackRock Inc. 19,905$169,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 26,418$224,0000.00%
View complete list of ARCTURUS THERAPEUTICS LTD shareholders